Literature DB >> 17491700

Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus.

Bernhard O Boehm, Jeffrey A Bluestone.   

Abstract

Entities:  

Year:  2005        PMID: 17491700      PMCID: PMC1783691          DOI: 10.1900/RDS.2004.1.156

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


× No keyword cloud information.
  57 in total

1.  Molecular basis of T cell inactivation by CTLA-4.

Authors:  K M Lee; E Chuang; M Griffin; R Khattri; D K Hong; W Zhang; D Straus; L E Samelson; C B Thompson; J A Bluestone
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

2.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

Authors:  A J McAdam; T T Chang; A E Lumelsky; E A Greenfield; V A Boussiotis; J S Duke-Cohan; T Chernova; N Malenkovich; C Jabs; V K Kuchroo; V Ling; M Collins; A H Sharpe; G J Freeman
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Authors:  B O Roep; M A Atkinson; P M van Endert; P A Gottlieb; S B Wilson; J A Sachs
Journal:  J Autoimmun       Date:  1999-09       Impact factor: 7.094

6.  CD28 costimulation promotes the production of Th2 cytokines.

Authors:  I C Rulifson; A I Sperling; P E Fields; F W Fitch; J A Bluestone
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

Review 7.  Regulation of T cell activation by CD28 and CTLA4.

Authors:  P J Noel; L H Boise; C B Thompson
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

8.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Authors:  D J Lenschow; K C Herold; L Rhee; B Patel; A Koons; H Y Qin; E Fuchs; B Singh; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

9.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.

Authors:  Hélène Bour-Jordan; Jane L Grogan; Qizhi Tang; Julie A Auger; Richard M Locksley; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2003-01-13       Impact factor: 25.606

View more
  2 in total

1.  The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy.

Authors:  David Thomas; Paola Zaccone; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2005-05-10

2.  Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.